dd Rich nations secured deals for half of COVID-19 vaccine

Rich nations secured deals for half of COVID-19 vaccine

Published: 17 Sep 2020 Updated: 19 Sep 2020   

Online Desk

A group of wealthy nations representing 13 percent of the global population have already bought up more than half of the promised doses of future Covid-19 vaccines, according to a report by Oxfam on Wednesday.

The non-governmental organisation analysed deals struck by pharmaceuticals and vaccine producers for the five leading vaccine candidates currently in late-stage trials, based on data collected by the analytics company Airfinity, reports NDTV.

"Access to a life-saving vaccine shouldn't depend on where you live or how much money you have," said Robert Silverman of Oxfam America.

"The development and approval of a safe and effective vaccine is crucial, but equally important is making sure the vaccines are available and affordable to everyone. Covid-19 anywhere is Covid-19 everywhere."

The five vaccines analyzed were from AstraZeneca, Gamaleya/Sputnik, Moderna, Pfizer and Sinovac.

Oxfam calculated the combined production capacity of these five vaccine candidates at 5.9 billion doses, enough for three billion people given that all five future vaccines will or are highly likely to require two doses.

Supply deals have so far been agreed for 5.3 billion doses, of which 2.7 billion (51 percent) have been bought by developed countries, territories and regions, including the US, UK, European Union, Australia, Hong Kong and Macau, Japan, Switzerland and Israel.

The remaining 2.6 billion doses have been bought by or promised to developing countries including India, Bangladesh, China, Brazil, Indonesia and Mexico, among others.

The non-profit added that one of the leading candidates, developed by Moderna, has received $2.5 billion in committed taxpayers' money, but has said it intends to make a profit and has sold the options for all its supply to rich nations.

Oxfam and other organizations are therefore calling for a "people's vaccine" free of charge, distributed fairly based on need.

"This will only be possible if pharmaceutical corporations allow vaccines to be produced as widely as possible by freely sharing their knowledge free of patents, instead of protecting their monopolies and selling to the highest bidder," Oxfam said.

PromotedListen to the latest songs, only on JioSaavn.com

It added that the estimated cost of providing a vaccine for everyone on Earth was less than one percent of the projected cost of Covid-19 to the global economy.

Read More

CU to hold admission test offline

CU to hold admission test offline

First year admission test of Chittagong University (CU) for 2020-21 ...

Mask-wearing is a state order: Cabinet

Mask-wearing is a state order: Cabinet

A cabinet meeting with Prime Minister Sheikh Hasina in the ...

Climate vulnerability, Covid 19 and steps towards SDG implementation

Climate vulnerability, Covid 19 and steps towards SDG implementation

We had only 112 baseline dada available out of 244 ...

Global coronavirus: Confirmed cases surpass 42.5 million

Global coronavirus: Confirmed cases surpass 42.5 million

As the coronavirus pandemic wreaking havoc worldwide, the number of ...

Shun unethical journalism: PM to journalists

Shun unethical journalism: PM to journalists

Prime Minister Sheikh Hasina on Sunday urged journalists to write ...

Samsung Electronics chairman Lee Kun-hee dies

Samsung Electronics chairman Lee Kun-hee dies

Chairman of South Korea's technological giant Samsung Electronics, Lee Kun-hee, ...

Suicide bombing kills 24 in Kabul

Suicide bombing kills 24 in Kabul

A suicide bombing at an education centre in Afghanistan's capital ...

12 new dengue cases reported

12 new dengue cases reported

Twelve new dengue cases were reported in the last 24 ...